Anna-Maria Krooupa

Dr. Anna-Maria Krooupa

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2016 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Open access
PDF file
DRD. Rhydderch
D. Rhydderch
AKAnna-Maria Krooupa
Anna-Maria Krooupa
GSG. Shefer
G. Shefer
RGR. Goulden
R. Goulden
PWP. Williams
P. Williams
CHClaire Henderson
Claire Henderson
Objective: This study evaluates English newspaper coverage of mental health topics between 2008 and 2014 to provide context for the concomitant improvement in public attitudes and seek evidence for changes in coverage.Method: Articles in 27 newspapers were retrieved using keyword searches on two randomly chosen days each month in 2008–2014, excluding 2012 due to restricted resources. Content analysis used a structured coding framework. Univariate logistic regression models were used to estimate the odds of each hypothesised element occurring each year compared to 2008.Results: There was a substantial increase in the number of articles covering mental health between 2008 and 2014. We found an increase in the proportion of antistigmatising articles which approached significance at P < 0.05 (OR = 1.21, P = 0.056). The decrease in stigmatising articles was not statistically significant (OR = 0.90, P = 0.312). There was a significant decrease in the proportion of articles featuring the stigmatising elements ‘danger to others’ and ‘personal responsibility’, and an increase in ‘hopeless victim’. There was a significant proportionate increase in articles featuring the antistigmatising elements ‘injustice’ and ‘stigma’, but a decrease in ‘sympathetic portrayal of people with mental illness’.Conclusion: We found a decrease in articles promoting ideas about dangerousness or mental illness being self‐inflicted, but an increase in articles portraying people as incapable. Yet, these findings were not consistent over time.

21 June 2024 in Cancers
Verified
Journal Article
Open access
PDF file
Ioulietta LazarouIoulietta Lazarou
Ioulietta Lazarou
AKAnna-Maria Krooupa
Anna-Maria Krooupa
Spiros NikolopoulosSpiros Nikolopoulos
Spiros Nikolopoulos
LALazaros Apostolidis
Lazaros Apostolidis
NSNikos Sarris
Nikos Sarris
Ioannis KompatsiarisIoannis Kompatsiaris
Ioannis Kompatsiaris
Digital health technologies have the potential to alleviate the increasing cancer burden. Incorporating patients’ perspectives on digital health tools has been identified as a critical determinant for their successful uptake in cancer care. The main objective of this scoping review was to provide an overview of the existing evidence on cancer patients’ perspectives and requirements for patient-facing digital health technologies. Three databases (CINAHL, MEDLINE, Science Direct) were searched and 128 studies were identified as eligible for inclusion. Web-based software/platforms, mobile or smartphone devices/applications, and remote sensing/wearable technologies employed for the delivery of interventions and patient monitoring were the most frequently employed technologies in cancer care. The abilities of digital tools to enable care management, user-friendliness, and facilitate patient–clinician interactions were the technological requirements predominantly considered as important by cancer patients. The findings from this review provide evidence that could inform future research on technology-associated parameters influencing cancer patients’ decisions regarding the uptake and adoption of patient-facing digital health technologies.

4 December 2018 in Epidemiology and Psychiatric Sciences
Verified
Journal Article
Open access
PDF file
CAC. Anderson
C. Anderson
ERE. J. Robinson
E. J. Robinson
AKAnna-Maria Krooupa
Anna-Maria Krooupa
CHClaire Henderson
Claire Henderson
Aims: Since 2008 England's anti-stigma programme Time to Change has lobbied media outlets about stigmatising coverage and worked with them to promote accurate and non-stigmatising coverage. While this may have an impact on coverage and hence attitudes, it is also possible that coverage can change in response to improving attitudes, through the creation of a market demand for less stigmatising coverage. This study evaluates English newspaper coverage of mental health topics between 2008 and 2016. Method: Articles covering mental health in 27 newspapers were retrieved using keyword searches on two randomly chosen days each month in 2008–2016, excluding 2012 and 2015 due to restricted resources. Content analysis used a structured coding framework. Univariate logistic regression models were used to estimate the odds of each hypothesised element occurring in 2016 compared with 2008 and Wald tests to assess the overall statistical significance of the year variable as the predictor. Results: The sample retrieved almost doubled between 2008 (n = 882) and 2016 (n = 1738). We found a significant increase in the proportion of anti-stigmatising articles (odds ratio (OR) 2.26 (95% confidence interval (CI) 1.86–2.74)) and a significant decrease in stigmatising articles (OR 0.62 (95% CI 0.51–0.75)). Reports on all diagnoses except for schizophrenia were more often anti-stigmatising than stigmatising. Conclusions: This is the first clear evidence of improvement in coverage since the start of Time to Change. However, coverage of schizophrenia may be less affected by this positive shift than that of other diagnoses. The increase in the level of coverage identified in 2016 requires further investigation, as it may also influence public conceptualisation of what constitutes mental illness, attitudes to mental illness in general and/or specific diagnoses. While most anti-stigma programmes are not diagnosis specific, we suggest their evaluation would benefit from a diagnosis specific approach to allow fuller interpretation of their effects. This could include media analysis driven by hypotheses based on diagnoses to ascertain whether variations by diagnosis over time occur both in the nature and in the proportion of coverage.

22 August 2019 in Palliative Medicine
Verified
Journal Article
Open access
PDF file
AKAnna-Maria Krooupa
Anna-Maria Krooupa
Bella VivatBella Vivat
Bella Vivat
SMStephen McKeever
Stephen McKeever
EMElena Marcus
Elena Marcus
JSJoseph Sawyer
Joseph Sawyer
PSPaddy Stone
Paddy Stone
The use of observational measures to assess palliative care patients’ level of consciousness may improve patient care and comfort. However, there is limited knowledge regarding the validity and reliability of these measures in palliative care settings. To identify and evaluate the psychometric performance of observational level of consciousness measures used in palliative care. Systematic review; PROSPERO registration: CRD42017073080. We searched six databases until November 2018, using search terms combining subject headings and free-text terms. Psychometric performance for each identified tool was appraised independently by two reviewers following established criteria for developing and evaluating health outcome measures. We found 35 different levels of consciousness tools used in 65 studies. Only seven studies reported information about psychometric performance of just eight tools. All other studies used either ad hoc measures for which no formal validation had been undertaken (n = 21) or established tools mainly developed and validated in non-palliative care settings (n = 37). The Consciousness Scale for Palliative Care and a modified version of the Richmond Agitation–Sedation Scale received the highest ratings in our appraisal, but, since psychometric evidence was limited, no tool could be assessed for all psychometric properties. An increasing number of studies in palliative care are using observational measures of level of consciousness. However, only a few of these tools have been tested for their psychometric performance in that context. Future research in this area should validate and/or refine the existing measures, rather than developing new tools.

9 February 2017 in European Journal of Neurology
Verified
Journal Article
Open access
PDF file
LRL. Ridsdale
L. Ridsdale
SPS. J. Philpott
S. J. Philpott
AKAnna-Maria Krooupa
Anna-Maria Krooupa
MMMyfanwy Morgan
Myfanwy Morgan
Having epilepsy requires individuals to learn about self-management. So far, trials of self-management courses have not included in-depth qualitative evaluations of how the learning method influences participants’ perceptions and behaviour. We aimed to interview participants who had attended a course, as part of a randomized controlled trial, to examine: (i) their perceptions of what they valued and negative aspects of the intervention, and (ii) whether and in what ways they continued to make use of the training. Twenty participants were selected within 6 months of undertaking a course from the larger randomized controlled trial conducted in England. Semi-structured interviews were based on a topic guide. Participants’ characteristics were representative of the clinical and demographic characteristics of the trial group. Their mean age was 44 years, half were male, and three-quarters had had epilepsy for over 10 years and had experienced one or more seizures in the previous month. Participants valued the opportunity to meet ‘people like them’. Structured learning methods encouraged them to share and compare feelings and experience. Specific benefits included: overcoming the sense of ‘being alone’ and improving self-acceptance through meeting people with similar experience. Over half reported that this, and comparison of attitudes and experience, helped them to improve their confidence to talk openly, and make changes in health behaviours. People feel socially isolated in long-term poorly controlled epilepsy. They gain confidence and self-acceptance from interactive groups. Expert-facilitated courses that encourage experiential learning can help people learn from each other, and this may enhance self-efficacy and behaviour change.

24 May 2022 in BMC Palliative Care
Verified
Journal Article
Open access
PDF file
AKAnna-Maria Krooupa
Anna-Maria Krooupa
PSPatrick Stone
Patrick Stone
SMStephen McKeever
Stephen McKeever
KSKathy Seddon
Kathy Seddon
SDSarah Davis
Sarah Davis
BVBella Vivat
Bella Vivat
Background: Bispectral index (BIS) monitoring uses electroencephalographic data as an indicator of patients’ consciousness level. This technology might be a useful adjunct to clinical observation when titrating sedative medications for palliative care patients. However, the use of BIS in palliative care generally, and in the UK in particular, is under-researched. A key area is this technology’s acceptability for palliative care service users. Ahead of trialling BIS in practice, and in order to ascertain whether such a trial would be reasonable, we conducted a study to explore UK palliative care patients’ and relatives’ perceptions of the technology, including whether they thought its use in palliative care practice would be acceptable.Methods: A qualitative exploration was undertaken. Participants were recruited through a UK hospice. Focus groups and semi-structured interviews were conducted with separate groups of palliative care patients, relatives of current patients, and bereaved relatives. We explored their views on acceptability of using BIS with palliative care patients, and analysed their responses following the five key stages of the Framework method.Results: We recruited 25 participants. There were ten current hospice patients in three focus groups, four relatives of current patients in one focus group and one individual interview, and eleven bereaved relatives in three focus groups and two individual interviews. Our study participants considered BIS acceptable for monitoring palliative care patients’ consciousness levels, and that it might be of use in end-of-life care, provided that it was additional to (rather than a replacement of) usual care, and patients and/or family members were involved in decisions about its use. Participants also noted that BIS, while possibly obtrusive, is not invasive, with some seeing it as equivalent to wearable technological devices such as activity watches.Conclusions: Participants considered BIS technology might be of benefit to palliative care as a non-intrusive means of assisting clinical assessment and decision-making at the end of life, and concluded that it would therefore be acceptable to trial the technology with patients.